Here’s your comprehensive guide to the 7 rights you should never compromise on:
- The Right to Complete Transparency in Medical Research
When you’re considering participating in research, transparency should be the foundation of every interaction. You deserve to know exactly how your data will be used, who will have access to it, how much compensation you’ll receive, and precisely how long each study will take. No surprises, no fine print, no last-minute changes.
At Joined Bio, we believe this transparency starts from the very first moment. Every study shows clear compensation details and time commitments upfront, because you deserve to make informed decisions about your participation. When research platforms operate in the shadows or use confusing language, they’re not respecting your time.
- The Right to Control Your Health Data
Your health information tells your unique story, and that story belongs to you. True patient empowerment means having the ability to decide exactly what information you’re comfortable sharing and who to share it with. Most importantly, you should have the right to revoke access to your data at any time, no questions asked.
This isn’t just about privacy; it’s about agency. You’re not a data point in someone’s spreadsheet. You’re a person with the power to decide how your health story helps advance medicine, and that power should remain firmly in your hands throughout the entire research process.
- The Right to Fair Compensation for Research Participation
Let’s be honest about something the research industry often tries to sidestep: your time, experiences, and health insights have real monetary value. When pharmaceutical companies and research institutions build billion-dollar breakthroughs, it’s often on the foundation of patient contributions.
Joined Bio offers transparent compensation up to $250 per study, ensuring participants receive fair value for their contributions. You deserve clear payment structures with no hidden fees or surprise deductions.
- The Right to Convenient, Dignified Research Participation
Research participation shouldn’t feel like a part-time job or require you to rearrange your entire life. The old model of research required participants to travel to clinical sites, sit in waiting rooms, and work around the researchers’ schedules. Modern technology and thoughtful design should mean you can contribute to groundbreaking studies while sitting on your couch.
Joined Bio has pioneered a home-based research model where licensed professionals come to you for specimen collection, surveys can be completed on your schedule, and the average study takes just 10 minutes on an average. Our approach to ethical research ensures studies fit into your life, not the other way around.
- The Right to HIPAA-Grade Privacy and Security
Your medical information is some of the most sensitive data that exists, and it deserves protection that matches its importance. But security isn’t just about technology, it’s about trust. When you share your health data for research, it should be used for exactly what you agreed to, nothing more and nothing less.
Joined Bio employs encryption, de-identification technology, and privacy and security features that reduce the chance of data breaches and identity exposure. We are committed to protecting your health data like it is our own.
- The Right to Withdraw from Research Studies Anytime
Consent in research isn’t a permanent commitment. It’s an ongoing agreement that you can modify or withdraw at any time. This flexibility recognizes that you’re a whole person with changing needs and circumstances.
Joined Bio’s flexible participation model lets you skip questions, take breaks, or completely withdraw from any study without penalty or judgment, putting participant autonomy first. Unlike rigid traditional research, we understand that life happens, priorities shift, and participant comfort always comes first.
- The Right to Respect as a Research Partner
Perhaps the most fundamental right is being treated with genuine respect. Your time matters. Your story matters. Your comfort matters. Your voice matters. This philosophy drives everything at Joined Bio, where participants are valued partners in advancing medicine, not just data sources.
Through our commitment to ethical patient research, we’re proving that the best research happens when patients are empowered partners, not passive participants.
Your Research, Your Choice
Say It Louder: “I will only participate in research that makes me feel like a human and not as a database of information.” Every time you choose to participate through a platform that respects your rights, you’re voting for a future where patient empowerment is the norm.
Ready to experience research done right? Join our growing community of empowered patients who are earning while advancing treatments for conditions that matter to them. Because when research respects your rights, everyone benefits.
Sign up & see which studies you qualify for. Connect your health data and start contributing today.
Learn more about patient privacy and security here. Join the Research Revolution!
]]>If you’re new here, Joined Bio is a trusted platform where people can easily contribute to medical research. You can participate by sharing insights through surveys or by contributing samples like blood, saliva, urine, etc to help advance medical discoveries while earning compensation. That trust didn’t happen by accident. We’ve intentionally built strong safeguards to protect the participants who make research possible. Because trust must be earned and continuously protected.
Let’s take a closer look at the measures we’ve put in place to ensure your data remains private, secure, and respected when you participate in research, so you can help advance science with confidence, not concern.
How We Protect Your Data
1. De-Identification: Separating You From Your Data
We protect your identity through advanced de-identification processes that ensure your personal information is not exposed to researchers. In simple terms, personal details such as names, addresses, and contact information are stored completely separate from your health data. Health records are assigned unique codes instead of identifying information. Only Joined Bio can reconnect your identity to your data in order to match you with relevant studies. Researchers receive fully de-identified data with no way to trace it back to you.
2. Encryption: Security You Can Trust
We use industry-standard security to help keep your information safe, always! All system requests are protected using secure access tokens and your data is encrypted even while it is being transmitted and stored.
We leverage Google’s built-in protections, which are designed to meet strict healthcare and security standards. We also take extra steps to protect your account. First, email verification helps ensure only you can sign in. Additionally, strong password requirements and regular update reminders add another layer of security. And finally, automatic session timeouts for inactive accounts help prevent accidental or unauthorized access.
3. Controlled Access: Protection at Every Level
Not everyone can access your data, and no one sees more than they need to. We enforce strict access controls to protect your information at all times.
How do we do that? Your data is stored in secure, monitored data centers with physical access restrictions in place. Role-based access controls ensure our staff can only view the data necessary to perform their responsibilities. We also conduct comprehensive background checks for employees who handle sensitive information. Ongoing security training helps ensure our team stays current on best practices and evolving privacy standards.
HIPAA Compliance Is at Our Core
As a healthcare technology company, Joined Bio follows the requirements of the ‘Health Insurance Portability and Accountability Act’, commonly known as HIPAA. Our approach goes beyond basic compliance and is embedded into how we design, operate, and continuously improve our platform.
This commitment includes clear and robust privacy policies, strong administrative, technical, and physical safeguards, and regular risk assessments to identify and address potential vulnerabilities. Additionally, our team receives regular training, oversight, and accountability to uphold these standards as regulations and best practices evolve. Because protecting health information is not a one-time effort, it requires constant attention and responsibility.
HIPAA compliance isn’t a checkbox for us. It’s the foundation that Joined Bio stands on that allows participants to engage in research with confidence, knowing their privacy and rights are taken seriously.
Our Privacy Commitment to You
1. You Are Empowered
Your participation is always your choice. You decide which research opportunities interest you, what information you want to share, and when you want to make changes. You can update your preferences at any time, or delete your data altogether, because control over your information should always remain with you.
2. You Get Transparency
We believe informed participants are empowered participants. That’s why we notify you when you’re matched with research studies, clearly explain how your data will be used, and present consent information in plain, easy-to-understand language.
3. Your Identity Is Yours
Your personal information is used solely to match you with relevant research opportunities, support your participation in studies, and process your compensation. Nothing more, and never without purpose. So share your health information with confidence, knowing your data is always in good hands.
Joined Bio’s Privacy & Security Promise
We treat your health information with the same care and respect we would want for our own families. Our commitment to privacy and security is not just about compliance. It is fundamental to our mission of advancing medical research while respecting individual rights.
On Data Privacy Day, we are proud to reaffirm that promise. And every day after, we continue to earn your trust.
]]>LEXINGTON, Mass., December 17, 2025
Joined Bio, the patient-powered research platform that’s reshaping how people participate in scientific research, today announced the launch of its Referral Program. This initiative introduces an earning model that allows individuals to grow their impact on medical discovery while increasing their own rewards.
The Referral Program represents an important step forward in Joined Bio’s mission to make research participation open, inclusive, and rewarding for everyone.
An Initiative for Participant-Driven Growth
At the center of the new referral system is the BioCircle, the official Joined Bio participant community that enables members to earn by expanding the network by involving their friends and loved ones.
“This program is about giving more value back to the people who make research possible,” said Jill Mullan, Co-CEO of Joined Bio. “Participants have consistently shared that they want more ways to contribute and more ways to benefit. The referral program reflects that need by placing the growth of research directly in the hands of the community.”
Participants are eligible to receive ten dollars each time they refer someone who joins using their personalized link. This allows individuals to earn through their own participation as well as when they invite others to join the BioCircle research community.
Simplicity and Accessibility at its Core
The referral process is clear and simple for both the existing participant and their invited friends.
Participants log in to their Joined Bio account, open their referral page, copy their unique link, and share it to earn ten dollars whenever one of their friends signs up and connects their health data. Invitees can just click the referral link, create a Joined Bio account, connect their healthcare data, and immediately unlock access to studies so they can start earning.
Reward payments are issued after the participant and their friend both connect their data and remain on the platform for thirty days.
Accelerating Breakthroughs by Expanding Access
By giving people more ways to contribute and increasing the value returned to them, the referral program strengthens Joined Bio’s vision for a research system shaped by the people it serves. The Company welcomes adults of all ages and health experiences, whether living with a condition, managing a rare disease, or completely healthy.
“Research only moves forward when real people take part,” said Dr. Christopher Ianelli, Co-CEO of Joined Bio. “Our referral program creates a ripple effect. Every new participant strengthens the data available to researchers, speeds up scientific progress, and brings us closer to breakthroughs that can change lives. It’s quite literally a BioCircle chain-reaction that we’re trying to achieve, with people at its core.”
More information about the referral program can be found at www.joined.bio/referral-program-terms/
About Joined Bio
Joined Bio is accelerating medical breakthroughs by connecting empowered patients with researchers who need their unique contributions. The company’s technology platform enables individuals to contribute biospecimens, health data, and real-world insights that drive medical breakthroughs while receiving fair compensation for their participation. By making research participation as simple as e-commerce, Joined Bio has built the infrastructure for the next generation of medical discoveries. Learn more at www.joined.bio.
Media Contact
Joined Bio Communications
450 Bedford Street
Lexington, MA 02420
Email: [email protected]
Phone: 978 219 4496
LEXINGTON, Mass., November 3, 2025 — Joined Bio, a revolutionary health technology company accelerating medical breakthroughs through patient-powered research, today announced the acquisition of DNAsimple, a pioneer in at-home, distributed research participation. The strategic acquisition unites DNAsimple’s established network of research participants with Joined Bio’s comprehensive biospecimen and real-world data platform, creating unprecedented opportunities for both participants and researchers.
From At-home Research Pioneer to Comprehensive Research Platform
DNAsimple got its start on ABC’s Shark Tank, where it revolutionized at-home research participation by making it simple for people to contribute DNA samples to important health studies. Now, as part of Joined Bio, DNAsimple participants gain access to a dramatically expanded universe of research opportunities and significantly higher earning potential.
“This isn’t just an acquisition, it’s an evolution,” said Dr. Olivier Noel, CEO and Founder of DNAsimple. “Our participants have always wanted to do more to help advance research for conditions affecting them and their loved ones. With Joined Bio’s platform and extensive researcher network, participants can now more readily contribute not just saliva samples, but blood, urine, and other biospecimens, share their medical records securely, and earn up to $250 per study. It’s everything we’ve wanted to offer our community.”
Enhanced Opportunities for DNAsimple Participants
Current DNAsimple participants will experience a seamless transition to the enhanced Joined Bio platform, with immediate access to expanded benefits:
- Up to $250 compensation per biospecimen study
- Multiple participation types: surveys and interviews, biospecimens (blood, saliva, urine, and more), and data studies
- Secure medical record integration for comprehensive data
- AI-powered matching to find perfect study fits
- Average of 10-minute participation time with home-based collection
Creating a New Standard for Patient-Powered Research
“DNAsimple built something special—a community of people who believe their health journeys can accelerate medical breakthroughs,” said Jill Mullan, Co-CEO of Joined Bio. “By combining their trusted participant relationships with our comprehensive research platform, we’re creating the gold standard for how research should work: patients are fairly compensated, researchers get the samples and data they desperately need, and breakthrough treatments reach patients faster.”
The acquisition strengthens Joined Bio’s position as the only platform executing complete biospecimen research studies with engaged patients, deep EMR data, and professional at-home collection. For researchers, this means access to a larger, more diverse participant pool with richer datasets. For participants, it means more opportunities to contribute to meaningful research while earning fair compensation.
Addressing a Multi-billion Dollar Research Challenge
Patient recruitment and data collection represent one of the largest bottlenecks in medical research, with pharmaceutical and biotech companies spending billions annually trying to find the right participants and biospecimens for their studies. Traditional approaches—using clinical trial sites, searching biobank inventories, or working through health systems are slow, expensive, and often fail to deliver the comprehensive data researchers need.
“Too many studies fail not because the science is wrong, but because researchers can’t find the right patients, the right samples, and the right data at the right time,” said Dr. Christopher Ianelli, Co-CEO of Joined Bio. “DNAsimple proved that patients want to participate when it’s easy and fair. We’re taking that model and scaling it across all of medical research.”
Maintaining Trust While Expanding Possibilities
DNAsimple participants can be assured that the same commitment to privacy, security, and participant control remains paramount. The Joined Bio platform provides robust HIPAA-grade security with complete data de-identification, while giving participants complete control over what data they share and with whom, and what study types they are interested in learning more about.
Dr. Noel will continue to play a key role in the transition, ensuring DNAsimple’s founding principles of participant empowerment and ethical research participation remain central to the expanded platform. “I’m personally committed to making sure our participants experience all the benefits of this evolution while maintaining the trust we’ve built over the years,” Dr. Noel stated.
Combined Platform Metrics
- 190,000 total participants across both platforms
- Coverage across all major therapeutic areas
- Licensed clinicians in all 50 states for specimen collection
- Secure integration with major electronic health record systems
Immediate Benefits for Current and New Participants
Current DNAsimple participants will receive communications over the coming weeks about accessing their enhanced benefits on the Joined Bio platform. New participants interested in contributing to medical research can join immediately at www.joined.bio.
“If you’ve been waiting for the right time to contribute to medical research, this is it,” added Dr. Ianelli. “You can help accelerate treatments for conditions affecting you and your loved ones, all while being rewarded for your invaluable contributions. It’s research as it should be.”
About Joined Bio
Joined Bio is accelerating medical breakthroughs by connecting empowered patients with researchers who need their unique contributions. The company’s technology platform enables individuals to contribute biospecimens, health data, and real-world insights that drive medical breakthroughs while receiving fair compensation for their participation. By making research participation as simple as e-commerce, Joined Bio is building the infrastructure for the next generation of medical discoveries. Learn more at www.joined.bio.
About DNAsimple
Founded by Dr. Olivier Noel, DNAsimple pioneered simple, accessible genetic research participation by connecting individuals with researchers seeking DNA samples for important studies. The platform democratized access to genetic research while ensuring participants were compensated for their contributions. DNAsimple’s legacy of participant empowerment and ethical research continues as part of the Joined Bio platform.
Media Contact:
Joined Bio PR Team
450 Bedford Street
Lexington, MA 02420
Email: [email protected]
Phone: 978-219-4496
]]>
LEXINGTON, Mass., October 29, 2025 — Joined Bio today unveiled a platform solving one of medical research’s most persistent bottlenecks: connecting qualified participants with studies that need access to biospecimens, health data, and patient insights. Using Joined Bio’s platform, participants can sign up, securely share their health records, join relevant studies, and earn up to $250 per study—all from home. Researchers running those studies gain instant access to engaged participants eager to accelerate medical breakthroughs.
Fixing a Broken System That Costs Billions
Patient recruitment consumes up to 40% of clinical research budgets, with pharmaceutical and biotech companies spending billions annually trying to find participants. Meanwhile, millions of patients managing chronic and acute conditions desperately want to contribute to research for treatments that could help them and their loved ones—but have no clear path to participate or get fairly compensated when they do.
“Too often, groundbreaking studies stall simply because recruiting the right participants becomes an impossible bottleneck,” said Dr. Christopher Ianelli, Co-CEO of Joined Bio. “We’re turning that bottleneck into an opportunity, creating a marketplace that works like e-commerce, where supply meets demand efficiently, transparently, and at scale.”
A Marketplace That Works for Everyone
Joined Bio’s platform revolutionizes research participation through three breakthrough capabilities: secure integration of comprehensive EMR data, intelligent participation matching, and nationwide in-home collection. Participants securely share their medical records and get matched to relevant studies based on their health profiles, earning up to $250 per study. Licensed clinicians handle all biospecimen collection at participants’ homes, eliminating travel burdens and increasing enrollment. Researchers gain access to perfectly matched participants, along with their specimens and rich, longitudinal health data.
“Participants deserve a research experience that respects their time, protects their health data, and rewards their contributions,” said Jill Mullan, Co-CEO of Joined Bio. “We’ve built a platform that does all three while solving researchers’ most persistent challenge: accessing the right participants, biospecimens, and data when they need them.”
For participants, the experience is designed for simplicity and control—signup takes 5 minutes, and most studies require just 10 minutes from home. For researchers, the platform eliminates traditional recruitment bottlenecks. They can define exact patient criteria and data needs, receive real-time feasibility assessments and cost estimates, and launch studies in days rather than months. The platform delivers specimens, EMR data, and patient insights on schedule, allowing scientists to focus on breakthrough discoveries rather than administrative logistics.
Built for Scale, Designed for Trust
The Joined Bio platform combines proven operational excellence with cutting-edge technology. The company’s data de-identification and encryption protocols form the foundation of its HIPAA-compliant infrastructure that protects each participant’s health data, while its IRB-approved protocols govern every aspect of research activity. A network of more than 5,000 licensed healthcare professionals across all 50 states enables nationwide biospecimen collection. Participants maintain complete control over which studies to join and what data to share, with intelligent matching technology connecting them to the most relevant research opportunities.
Building on Proven Success
Joined Bio has strategically assembled leading capabilities in patient recruitment and biospecimen management, including recent acquisitions of established companies that bring deep expertise in clinical research participation and biospecimen sourcing. These initial cornerstone acquisitions provide immediate operational scale while the company continues building its next-generation technology infrastructure.
“We’re not starting from scratch—we’re building on years of operational excellence and trusted participant relationships,” noted Mullan. “This allows us to deliver value immediately while developing the AI and automation capabilities that will further transform the industry.”
Immediate Impact at Scale
The platform launches with significant momentum. More than one hundred thousand participants (100,000) already on the platform stand ready to contribute across all therapeutic areas, with active studies already underway in heart disease, autoimmune diseases, neurological disorders, and more. Partnerships with leading pharmaceutical and biotech companies provide immediate market traction, while coverage across all major U.S. metropolitan areas ensures broad geographic reach.
Joined Bio Launches BioCircle Community for Research Participants
Joined Bio also announced the launch of its BioCircle, a community of empowered research participants. BioCircle welcomes individuals managing chronic conditions, those supporting loved ones through health challenges, and anyone who believes in advancing medical science.
“Every person’s health journey contains insights that could lead to the next breakthrough,” said Ianelli. “We’re creating a world where those insights are valued, compensated, and channeled directly to researchers working on tomorrow’s cures.”
About Joined Bio
Joined Bio is accelerating medical breakthroughs by connecting empowered patients with researchers who need their unique contributions. The company’s technology platform enables individuals to contribute biospecimens, health data, and real-world insights that drive medical breakthroughs while receiving fair compensation for their participation. By making research participation as simple as e-commerce, Joined Bio is building the infrastructure for the next generation of medical discoveries. Learn more at www.joined.bio.
Media Contact:
Joined Bio Communications
450 Bedford Street
Lexington, MA 02420
Email: [email protected]
Phone: 978-219-4496
Website: www.joined.bio
]]>This isn’t an accident—it’s how the system was designed. While patients provide the raw material that powers a massive data economy, they’ve been systematically excluded from participating in the financial benefits their information generates. It’s time to examine how this system works, who profits from it, and why patients deserve better.
The Hidden Health Data Economy
Most patients have no idea their health information is being bought and sold. When you think about your medical records, you probably imagine a private file that only you and your healthcare providers can access. The reality is far more complex and commercially driven.
Healthcare systems regularly license anonymized patient data to pharmaceutical companies, with some major health systems generating tens of millions of dollars annually from these agreements. Insurance companies sell insights derived from patient claims data to help other businesses assess health risks and market opportunities. Technology companies pay premium prices to access electronic health records, using this information to train artificial intelligence systems and develop new medical devices.
The global health data market is projected to exceed $70 billion by 2025, with patient-generated data representing the foundation of this entire economy. Data brokers aggregate health information from multiple sources and sell it to clients ranging from pharmaceutical companies to investment firms looking to predict which healthcare stocks might outperform.
Electronic health record companies like Epic and Cerner have built business models that include monetizing the patient data stored in their systems. Research institutions partner with corporations to provide access to patient databases in exchange for significant funding. Even seemingly innocuous health apps often generate revenue by selling user data to third parties.
Who’s Making Money From Your Health Data
The list of entities profiting from patient health information is longer than most people realize, spanning industries far beyond healthcare itself.
Pharmaceutical companies represent the largest purchasers of health data, spending billions annually to access patient information that helps them identify drug targets, understand treatment effectiveness, and design clinical trials. When a pharmaceutical company develops a blockbuster drug partly based on insights from patient data analysis, patients see none of the resulting profits despite providing the foundational information.
Technology giants including Google, Amazon, Microsoft, and Apple have all invested heavily in acquiring health data to power their artificial intelligence and cloud computing services. These companies often pay healthcare systems substantial sums for data access, then use that information to build products and services they sell back to the healthcare industry.
Insurance companies use patient data not just to set premiums, but also to develop new products and identify market opportunities. They analyze patterns in claims data to predict future healthcare trends, information that has significant commercial value for business planning and investment decisions.
Data brokers and analytics firms serve as intermediaries, aggregating health information from multiple sources and packaging it for sale to various industries. Companies like IQVIA (formerly IMS Health) generate billions in revenue by providing pharmaceutical companies with detailed insights derived from patient data.
Healthcare systems themselves have discovered that their patient databases represent valuable assets. Major health systems now employ dedicated teams to monetize their data through partnerships, licensing agreements, and research collaborations that generate significant non-patient revenue.
Investment firms and hedge funds purchase health data to gain insights that inform their trading strategies, particularly for healthcare and pharmaceutical stocks. Patient health trends can provide early indicators of market opportunities that translate into substantial financial gains for these firms.
The Patient Paradox
The irony of this system is striking: patients provide 100% of the raw material for the health data economy but receive 0% of the direct financial benefits. While everyone else in the ecosystem has found ways to monetize patient information, patients themselves remain excluded from the value chain they make possible.
This exclusion isn’t just about money—it’s about control and recognition. Patients currently have little say in how their health information is used commercially, which companies gain access to it, or what products and services result from their data. They’re treated as passive sources of information rather than active partners in the data economy their health experiences create.
The current model also creates perverse incentives. While pharmaceutical companies and technology firms have strong financial motivations to access patient data, patients have little incentive to ensure their information is complete, accurate, or actively contributed to research efforts. This misalignment reduces the quality and quantity of data available for medical research and commercial development.
Why Patients Deserve Better
The argument for including patients in the health data economy isn’t just about fairness—it’s about creating better outcomes for everyone involved.
Patients deserve compensation for value creation. When someone’s health information contributes to the development of a profitable treatment or diagnostic tool, they should share in that success. The current system privatizes the gains while socializing the risks, allowing companies to profit from patient data while patients bear all the healthcare costs and receive none of the financial benefits.
Better incentives lead to better data. When patients have financial stakes in research outcomes, they’re more likely to provide complete, accurate information and actively participate in studies. This higher-quality data leads to better research results and faster medical breakthroughs that benefit everyone.
Patient participation should be voluntary and transparent. Rather than having their data used without explicit consent or compensation, patients should be able to choose which research projects and commercial applications they want to support, with clear understanding of how their information will be used and what benefits they might receive.
Innovation accelerates with aligned interests. When patients are true partners in the data economy rather than just sources of raw material, the entire system becomes more efficient and effective. Patients become advocates for research rather than passive participants, leading to faster enrollment in studies and more comprehensive data collection.
Joined Bio: A New Model for Patient Partnership
While the current health data economy excludes patients from financial participation, new models are emerging that recognize patients as true partners deserving of compensation for the value their health information creates.
Joined Bio represents a fundamental shift in how the health data economy can work. Instead of treating patients as passive sources of information, Joined Bio creates a platform where patients maintain control over their health data while participating directly in the commercial value it generates.
Through Joined Bio’s platform, patients can choose to contribute their health information to research projects and commercial applications while retaining ownership and control over their data. When that information contributes to successful treatments, diagnostic tools, or other medical innovations, patients share in the financial benefits rather than watching others profit from their health experiences.
This model doesn’t just provide patients with fair compensation—it creates better incentives for high-quality research participation. Patients who benefit financially from successful research outcomes have strong motivations to provide accurate, complete health information and to participate actively in ongoing studies.
Joined Bio also provides transparency that the current system lacks. Patients can see exactly which research projects and companies are using their data, how that information is being applied, and what results emerge from studies that include their health information. This visibility helps patients make informed decisions about their participation while maintaining control over their health data.
The Technology That Makes Change Possible
Recent advances in data security, AI technology, and privacy-preserving analytics have made it possible to create patient-controlled health data platforms that maintain the privacy protections patients need while enabling the data sharing that drives medical research.
These technologies allow patients to contribute their health information to research while maintaining complete control over who accesses their data and for what purposes. Smart contracts can automatically distribute compensation to patients when research using their data leads to successful outcomes, creating a transparent and fair system for sharing the value that patient data creates.
Sophisticated anonymization and aggregation techniques ensure that patient privacy is protected even as their data contributes to commercial research and development. Patients can participate in the data economy without sacrificing the confidentiality that traditional medical research has always provided.
What This Means for the Future
The exclusion of patients from the health data economy isn’t just unfair—it’s unsustainable. As patients become more aware of how their health information is being monetized, they’re increasingly demanding transparency, control, and fair compensation.
Healthcare systems, pharmaceutical companies, and technology firms that continue to treat patients as passive sources of free data will find themselves at a disadvantage compared to organizations that embrace patient partnership models. The companies that recognize patients as valuable partners rather than just data sources will have access to higher-quality information, more willing participants, and stronger relationships with the communities they serve.
For patients, the emergence of platforms like Joined Bio represents an opportunity to participate actively in the health data economy rather than being exploited by it. Instead of watching others profit from their health experiences, patients can become partners in the research and development process while maintaining control over their personal information.
Taking Control of Your Health Data Value
The current health data economy treats patients as a resource to be extracted from rather than partners to collaborate with. This model has generated enormous profits for healthcare companies, pharmaceutical firms, and technology giants while providing patients with nothing more than the promise of eventually benefiting from improved treatments.
Patients don’t have to accept this arrangement. New platforms and partnership models are emerging that recognize patients as the valuable contributors they’ve always been. By choosing to participate in patient-controlled research platforms, you can maintain ownership of your health data while sharing in the value it creates.
Your health information has always been valuable—now you have the opportunity to benefit from that value rather than simply watching others profit from it. The choice is whether you’ll continue to be a passive source of free data for others’ commercial benefit, or become an active partner in the health data economy your information makes possible.
The billion-dollar health data economy exists because of patients like you. It’s time patients like you started benefiting from the value you create.
]]>Your Health Data: More Valuable Than You Realize
When you think about your medical records, you might picture a simple file with your test results and doctor’s notes. In reality, your health information represents something far more significant. Each piece of data—your blood pressure readings, how you respond to medications, your family history, even how you describe your symptoms—becomes part of humanity’s growing understanding of health and disease.
The medication helping you today exists because thousands of patients before you shared similar health experiences that researchers could analyze. The diagnostic test that caught your condition early was developed by studying patterns across countless cases like yours. Your individual health journey, when combined with millions of others, creates a powerful engine for medical advancement.
When Data Becomes Discovery
Understanding the true value of your data becomes clearer when you see how it transforms into real medical breakthroughs. Researchers analyzing electronic health records discovered that a diabetes medication also helped patients lose significant weight, leading to entirely new obesity treatments now used by millions. By studying genetic data from thousands of cancer patients, scientists revealed why certain people respond better to specific therapies, enabling doctors to personalize treatment approaches that dramatically improve outcomes.
When patients with rare diseases share their health information through research databases, they enable researchers to identify patterns that would be impossible to detect with just a few cases. This collective sharing has led to new treatments for conditions that were previously considered hopeless.
These discoveries don’t happen by accident—they emerge from the systematic analysis of patient data at scale. Your individual contribution might seem small, but when combined with others, it becomes part of something transformative.
The Ripple Effects of Your Participation
Whether you actively participate in research studies or simply receive regular healthcare, your data creates expanding circles of impact that extend far beyond your individual care.
For people with your specific health conditions, researchers use data from patients like you to identify which treatments work best for people with similar characteristics, leading to more effective care protocols. Children born today will benefit from better treatments and earlier detection methods developed using today’s health data. By identifying patterns across large populations, researchers develop prevention strategies that stop diseases before they start.
Perhaps most importantly, when diverse patient populations participate in research, the resulting treatments work better for everyone. Medical research has historically been skewed toward certain demographic groups, but broader participation helps ensure that new treatments are effective across different ages, ethnicities, and backgrounds.
Your participation in this system—whether active or passive—contributes to each of these outcomes. The impact of your health information extends across generations and communities, creating a legacy of better health for countless people you’ll never meet.
Privacy, Protection, and Participation
You don’t need to wait for others to create opportunities for meaningful participation in health research. There are practical steps you can take to ensure your health information contributes to medical progress while maintaining control over how it’s used.
Keep your medical records comprehensive and up-to-date, including accurate information about symptoms, side effects, and treatment responses. This detailed information helps your care team provide better treatment while contributing higher-quality data to research efforts. When healthcare systems send surveys about your experience and outcomes, participate actively—these responses directly influence quality improvement initiatives and research priorities.
Consider joining patient registries related to your health conditions. These databases allow researchers to better understand diseases and develop improved treatments, and they often provide participants with updates about research findings relevant to their conditions.
Most importantly, seek out research opportunities actively rather than waiting for them to come to you. Look for patient-centered research platforms like Joined Bio that put you in control of your data while creating meaningful opportunities to contribute to medical discovery. Research participation is evolving beyond traditional clinical trials to include data partnerships where your ongoing health information contributes to continuous discovery while ensuring you remain an active partner in the process.
A New Model for the Future
The future of medicine promises treatments tailored to individual genetic profiles, lifestyle factors, and health histories. This precision medicine approach is only possible because patients have shared their health information to build the comprehensive knowledge base that personalized care requires.
As artificial intelligence and advanced analytics become more sophisticated, the potential for your health data to contribute to discoveries grows exponentially. AI systems can now analyze patterns in millions of patient records to identify promising treatment approaches, predict which patients might develop certain conditions, and discover entirely new uses for existing medications.
But the technology enabling these advances also makes possible new approaches to health research—ones where patients can be recognized as true partners in the discovery process rather than simply contributors of raw data.
Emerging research models maintain the scientific rigor and privacy protections of traditional research while creating new opportunities for patients to participate more actively and meaningfully in medical discovery. These approaches recognize that the people whose health experiences drive medical breakthroughs deserve to have more control over how their data is used and to participate more directly in the research process that leads to better treatments for everyone.
Your Role in Shaping Healthcare’s Future
Every piece of health information you generate—from routine blood work to your response to a new medication—adds to humanity’s understanding of health and disease. When multiplied across millions of patients, these individual contributions create an unprecedented resource for medical discovery.
The question isn’t whether your health data will contribute to medical research—it already is. The question is whether you’ll have a say in how that contribution is recognized and rewarded.
You have the opportunity to be more than a passive source of data in someone else’s research project. You can be an active partner in discovery, maintaining control over your information while participating in research that benefits both your health and your financial wellbeing. When research using your data leads to new treatments or diagnostic tools, you can share in that success.
Your health journey is uniquely yours, but its impact extends far beyond your individual experience. By choosing to participate actively in research partnerships that recognize your contribution, you’re not just helping advance medical science—you’re helping create a more equitable model for how medical discovery works.
The future of healthcare will be built on the foundation of patient data and patient participation. The choice you face is whether you’ll help build that future as a partner who shares in its benefits, or remain on the sidelines while others profit from the value your health information creates.
Your data tells your health story. But when combined with millions of others in the right partnership model, it also helps write the next chapter of medical science—and you should be part of that story’s success.
]]>The Research Participation Crisis
The statistics are stark: 85% of clinical research sites struggle to meet enrollment targets, and studies routinely take months or even years to find suitable participants. But behind these numbers lies a deeper problem—researchers and patients have been operating in separate worlds, with limited connection between those who need answers and those who can provide them.
Traditional research recruitment relies on outdated methods: posting flyers in waiting rooms, hoping word-of-mouth will reach the right people, or working through overburdened clinical coordinators who manually screen potential participants. Meanwhile, patients with conditions that could benefit from research often never learn about relevant studies, or discover them too late to participate.
What Patient Power Really Means
Patient power isn’t just about giving people a voice—it’s about fundamentally restructuring how research operates. When patients are truly empowered, they become active partners who:
· Control their participation: Rather than being recruited by chance, patients can actively seek out research opportunities that align with their health goals and interests.
· Share meaningful data: Instead of limited clinical snapshots, patients can contribute comprehensive health histories that provide researchers with richer, more accurate datasets.
· Maintain ownership: Patients decide how their data is used, which studies they join, and how much they want to contribute—while being fairly compensated for their valuable contributions.
· Drive research priorities: When patients have a direct line to researchers, they can help ensure studies address the questions that matter most to those living with specific conditions.
The Technology That Makes It Possible
Modern technology has finally made true patient empowerment feasible. AI can analyze vast amounts of health data to match patients with relevant studies in real-time. Secure platforms can protect patient privacy while enabling seamless data sharing. Digital tools can bring research participation directly to patients’ homes, eliminating geographical barriers and scheduling conflicts.
But technology alone isn’t enough. The real transformation comes from changing the relationship between researchers and patients from one of recruitment to one of partnership.
Breaking Down the Barriers
The traditional research model created artificial barriers between patients and researchers:
· Information asymmetry: Patients rarely knew what studies were available or whether they might qualify.
· Geographic limitations: Research opportunities were concentrated in major medical centers, excluding patients in rural or underserved areas.
· Complex bureaucracy: Participation required navigating complicated systems that weren’t designed with patient experience in mind.
Patient-powered research eliminates these barriers by putting patients in the driver’s seat. When patients can easily discover relevant studies, understand what participation involves, and connect directly with research teams, the entire process becomes more efficient and effective.
Real Impact on Scientific Discovery
When patients become active partners in research, the benefits extend far beyond improved enrollment numbers:
· Faster discoveries: Studies that would have taken years to enroll can be completed in months, accelerating the path from research to treatment.
· Better data quality: Engaged patients provide more accurate, comprehensive information than those who feel like passive subjects.
· More diverse participation: When research is accessible to patients everywhere, studies can include more diverse populations, leading to treatments that work for everyone.
· Patient-relevant outcomes: Research driven by patient priorities focuses on the endpoints that matter most to those living with conditions.
The Ripple Effect
Patient empowerment creates positive feedback loops throughout the research ecosystem. When patients see that their participation leads to meaningful discoveries, they become advocates who encourage others to get involved. When researchers experience the benefits of working with engaged patient partners, they design studies that are more patient-friendly and accessible.
Healthcare providers begin to see research participation as a valuable treatment option rather than an administrative burden. Regulatory agencies recognize that patient-driven research produces higher-quality evidence. The entire system becomes more efficient, effective, and ethical.
The Path Forward
The future of medical research isn’t just about new technologies or increased funding—it’s about recognizing that patients are the most underutilized resource in the research ecosystem. Every day that we fail to tap into patient power, we miss opportunities for discoveries that could transform lives.
The organizations and researchers who embrace patient empowerment today will be the ones driving tomorrow’s breakthroughs. They’ll have access to more diverse, engaged participants. They’ll generate higher-quality data. And most importantly, they’ll be conducting research that truly serves the people it’s meant to help.
Patient power isn’t the missing link in research—it’s the foundation upon which all meaningful medical progress is built. The question isn’t whether we can afford to empower patients in research. The question is whether we can afford not to.
Ready to Experience Patient-Powered Research?
If you’re a patient interested in contributing to meaningful research, or a researcher looking to connect with engaged participants, the tools to make it happen are available today. The future of medical discovery depends on patients and researchers working together as true partners.
Are you ready to be part of the solution? Let us know!
]]>In his new role, Erik will focus on sales strategy and business development, working to bring new research projects to Joined Bio utilizing both the company’s established healthcare provider network and emerging direct-to-patient capabilities.
“Erik brings that rare combination of deep biospecimen expertise and the ability to translate complex requirements into clear researcher value,” said Chris Ianelli, Co-CEO and Founder of Joined Bio. “At a time when traditional procurement is failing researchers, Erik knows how to demonstrate that our platform delivers results, not roadblocks.”
Scaling Operations Following Strategic Acquisition
Erik’s appointment comes on the heels of Joined Bio’s acquisition of BioSample Connect, which expanded the company’s healthcare provider network and operational capabilities. This strategic combination positions Joined Bio to scale biospecimen services immediately while developing its direct-to-patient marketplace platform that will eliminate traditional procurement bottlenecks.
The timing addresses critical industry pain points, with 85% of clinical research sites struggling to meet enrollment targets and biospecimen studies traditionally taking months to launch. Erik will focus on demonstrating how Joined Bio’s dual approach reduces these timelines while expanding access to diverse patient populations.
“I’m excited to join Joined Bio at this pivotal moment,” said Erik Uribe, Head of Commercialization. “The BioSample Connect acquisition combined with the company’s innovative direct-to-patient vision creates immediate sales opportunities while positioning us at the forefront of industry transformation.”
Prior to joining Joined Bio, Erik held senior commercialization roles at Discovery Life Sciences, iSpecimen, and Audubon Biosciences, where he was instrumental in growing their respective leadership positions in the biospecimen market. His experience spans inside sales, direct sales, sales operations, and company integrations, which uniquely positions him to execute Joined Bio’s multi-faceted growth strategy while seamlessly integrating the newly acquired BioSample Connect operations.
About Joined Bio
Joined Bio is creating a revolutionary marketplace that reimagines how medical research connects with patient participation. The company’s AI-powered platform securely analyzes electronic health records—with patient consent—to precisely match researchers with willing participants. Joined Bio also operates as a full-service biospecimen provider, sourcing samples through its established healthcare provider network. This dual approach enables rapid specimen collection and comprehensive data sharing while empowering patients to control their research involvement and earn compensation. For researchers, it means efficient access to ideal study candidates and their biospecimens, accelerating the pace of scientific discovery. For more information, visit www.joined.bio.
]]>
Understanding Vitiligo: More Than Skin Deep
Vitiligo affects approximately 1-2% of the global population, causing the immune system to attack melanocytes—the cells responsible for producing skin pigment. While the physical manifestation appears as white patches on the skin, the condition’s impact extends far beyond the visible. Many individuals with vitiligo face emotional challenges as well as the physical challenges – benefitting from both medical solutions and community support.
The complexity of vitiligo—with its varied presentations, unpredictable progression, and multifaceted underlying mechanisms—makes it a condition that demands not just scientific inquiry, but collective action from researchers, patients, advocates, and the broader community.
The Transformative Power of Community
World Vitiligo Day exemplifies how community mobilization can shift narratives and accelerate progress. What began as a grassroots movement has evolved into a global phenomenon that brings together patients, families, healthcare providers, researchers, and organizations united by a common purpose: to improve outcomes for those affected by vitiligo.
This community strength manifests in multiple ways. Patient advocacy groups provide crucial emotional support and shared experiences that help individuals navigate their vitiligo journey with greater confidence. Online communities break down geographical barriers, connecting people across continents who share similar challenges and triumphs. Healthcare providers benefit from patient insights that inform more compassionate and effective treatment approaches.
Perhaps most importantly, this collective voice has the power to influence research priorities and funding decisions. When communities speak with unity about their needs, the scientific and medical establishments listen.
Why Community Investment in Research Matters
The path from laboratory discovery to meaningful treatment is long, complex, and expensive. Traditional funding mechanisms, while essential, often fall short of addressing the full spectrum of research needs—particularly for conditions like vitiligo that may not receive the same level of attention as more prevalent diseases.
Community investment in research creates several critical advantages:
· Accelerated Innovation: Community funding can support early-stage, high-risk research that might struggle to secure traditional grants. This includes exploratory studies, novel therapeutic approaches, and interdisciplinary collaborations that could lead to breakthrough discoveries.
· Patient-Centered Research Priorities: When communities invest in research, they ensure that scientific efforts align with real-world patient needs. This leads to more relevant studies, better outcome measures, and ultimately more meaningful advances.
· Sustained Momentum: Community support provides consistent funding that can bridge gaps between larger grants, maintaining research continuity and preventing promising projects from stalling.
· Democratized Science: Community involvement in research funding creates opportunities for greater transparency and engagement, fostering trust between researchers and the populations they serve.
Building Bridges Between Hope and Discovery
At Joined Bio, we understand that transformative treatments emerge not just from isolated laboratory work, but from the dynamic intersection of scientific expertise and community engagement. The vitiligo community’s commitment to supporting research represents a powerful model for how patient advocacy can drive medical progress.
This collaborative approach recognizes that everyone has a role to play. Patients contribute through participation in research and sharing their experiences. Families provide support networks that enable research participation. Healthcare providers bridge the gap between laboratory findings and clinical application. Organizations like ours work connect willing patient participants with research that’s important to them.
Looking Forward: A Shared Vision
As we observe World Vitiligo Day, we’re reminded that progress in medical research is not just about the science—it’s about the people behind the science and the communities that champion it. The vitiligo community’s dedication to supporting research demonstrates how collective action can accelerate the journey from today’s challenges to tomorrow’s solutions.
The investment of community resources in research represents more than financial support; it’s an investment in hope, in possibility, and in the belief that together, we can create a future where vitiligo is not just understood, but effectively treated.
Today, we celebrate not only World Vitiligo Day, but the power of community to drive meaningful change. We honor the patients, families, advocates, and supporters who refuse to accept the status quo and instead choose to invest in a better tomorrow.
At Joined Bio, we’re proud to be part of this community-driven research ecosystem, working alongside all stakeholders to transform hope into tangible progress. This commitment to community extends beyond our research—it’s personal. Today, our colleague Bill Arteca is speaking at a vitiligo conference, sharing his expertise not just as a professional in our field, but as someone who lives with vitiligo himself. His voice represents the powerful intersection of lived experience and scientific innovation that makes our work so meaningful.
World Vitiligo Day serves as an annual reminder that progress happens when communities unite behind a common cause. To learn more about how you can support vitiligo research and connect with the global vitiligo community, visit www.vrfoundation.org.
]]>